Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and ...

During your visit, your healthcare professional will likely review your medical history, perform a physical exam, and discuss your current lifestyle to determine whether Wegovy is right for you.

Wegovy may significantly reduce hospital admissions for any cause and overall length of stay, according to a new analysis of data from Novo Nordisk's phase 3 SELECT trial.

In addition, the American Gastroenterological Association includes Wegovy in its treatment recommendations for obesity. A large review of studies compared GLP-1 agonist medications, including ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

One shipment of suspected counterfeit Wegovy was hidden inside a Mickey Mouse puzzle for ... users to verify if a website selling medications has been vetted. You can also review a list of the current ...

Patients should review all potential side effects and discuss any concerns with their healthcare provider before starting the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Previously, the lowest dose of Wegovy, 25 milligrams, was listed as in short supply. Since early 2022, several doses of semaglutide — the active ingredient in Wegovy and Ozempic — had been on the ...

Wegovy (semaglutide) is an injectable medication ... Semaglutide for the treatment of overweight and obesity: A review. Diabetes Obes Metab. 2023;25(1):18-35. doi:10.1111/dom.